Efficacy and Safety of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma: A Prospective Multi-center Phase II Study of by the Puget Sound Oncology Consortium (PSOC)

We conducted a multi-center phase II trial of gemcitabine (G), carboplatin (C), dexamethasone (D), and rituximab (R) in order to examine its safety and efficacy as an outpatient salvage regimen for lymphoma. Fifty-one patients received 2–4 21-day cycles of G (1000mg/m(2), days 1 and 8), C (AUC=5, da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gopal, Ajay K., Press, Oliver W., Shustov, Andrei R., Petersdorf, Stephen H., Gooley, Ted A., Daniels, Jasmine T., Garrison, Mitchell A., Gjerset, George F., Lonergan, Matthew, Murphy, Anne E., Smith, Julie C., Pagel, John M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018339/
https://ncbi.nlm.nih.gov/pubmed/20578815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.491137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados